Financing channel feed – Endpoints News

Financing channel feed

Bayer starts work on $43M+ expansion of OTC manufacturing site in Pennsylvania

3 years ago

A fledgling biotech goes SPAC route to bankroll cancer vaccine, CAR-T and CD47

3 years ago

Pfizer backs $60M infusion into Carrick, teams up on breast cancer treatment

3 years ago

Pfizer will invest $1.2B+ in Irish manufacturing site, adding 500 employees

3 years ago

Intellia and Iveric sell stocks to raise money, each netting $300M

3 years ago

CRO startup Vial scores $67M Series B led by General Catalyst

3 years ago

BioNTech bets on difficult STING field via small molecule pact with a Polish biotech

3 years ago

Lundbeck-partnered preclinical biotech nabs Series A from AstraZeneca

3 years ago

Cajal Neuroscience launches with $96M Series A, tackling Alzheimer's and Parkinson's

3 years ago

San Diego biotech lands $120M to launch a slate of trials in neurosensory disorders

3 years ago

Lilly joins in expanded Series A round for BeiGene-partnered mRNA biotech

3 years ago

Scoop: Versant, NEA launch new biotech helmed by ex-CEO of protein degrader C4 Therapeutics

3 years ago

German biotech CatalYm raises $50M to flip weight loss target for cancer

3 years ago

Simulations for experiments: Bayer-backed startup lands $20M to test out its tech

3 years ago

Six-person ALS biotech wants to go public — but it’s also pivoting from earlier plans

3 years ago

With the clinic in sight, Greg Verdine's startup bags $178M for new class of targeted therapies

3 years ago

Plexxikon vets kick off new drug discovery outfit — with old assets and new target

3 years ago

European protein software startup Cradle launches with backing from Lyft, Twist CEOs

3 years ago

Emergent scores a DoD award to evaluate its chikungunya vaccine in the field

3 years ago

Tenaya bags $75M from stock sale as it prepares to put a gene therapy for heart disease into the clinic

3 years ago

Scorpion Capital goes after Twist Bioscience as latest synbio target, comparing biotech to Theranos

3 years ago

Following ASCO showing, Bert Vogelstein’s latest startup launches into recurrent cancer detection

3 years ago

A rare biotech IPO lands on Nasdaq, boosted by RA Capital and a former Eli Lilly drug

3 years ago

Can an oncolytic virus therapy challenge the standard of care in bladder cancer? CG Oncology has $120M to find out

3 years ago

First page Previous page 42 43 444546 47 48 Next page Last page